(IPV) |
| 0 (0%) 09-11 06:13 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.04 |
| Resistance 1: | 0.03 |
| Pivot price: | 0.00 |
| Support 1: | 0.01 |
| Support 2: | 0.00 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -38.000 |
| Book Value | 0.630 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.025 |
| Profit Margin (%) | -76.75 |
| Operating Margin (%) | -45.58 |
| Return on Assets (ttm) | -24.0 |
| Return on Equity (ttm) | -331.8 |
Company news
Thu, 10 Sep 2026
2026-2027 Research Roundtable Series: IPV & Health - Johns Hopkins Bloomberg School of Public Health
Tue, 08 Sep 2026
Psychological drivers of men’s perpetration of intimate partner violence against women - nature.com
Tue, 01 Sep 2026
Exposure to Domestic Violence/Intimate Partner Violence Is Associated With Child Welfare System Involvement - HHS.gov
Mon, 24 Aug 2026
Yale Researchers Study Military-to-Civilian Transition Stressors Associated with Couples’ Intimate Partner Violence - Yale School of Medicine
Thu, 30 Jul 2026
Recommendations for VA on addressing intimate partner violence issued by expert panel - Keck School of Medicine of USC
Sat, 11 Jul 2026
Early Education on Intimate Partner Violence in Undergraduate Medical Training: A Narrative Review on Timing, Methods, and Clinical Preparedness - Cureus
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
